 Chromadex NASDAQ:CDXCs stock had its buy rating reiterated by equities research analysts at B. Riley in a research note issued on Tuesday, TipRanks reports. They presently have a 7.00 target price on the stock. B. Rileys price target would indicate a potential upside of 40.00 from the companys previous close. Several other research firms also ... 